FENUGREC
Food supplement declared in France, declaration No 2016-7-769
FENUGREC (ACB PHARMA) is a food supplement declared in France. Status: retiré du marché le 9 October 2024. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- ACB PHARMA
- Food business operator placing the product on the market
- ACBNature
- Status
- Retiré du marché le 9 October 2024
- Form
- Gélule
- Daily dose
- 3
- Directions for use
- A utiliser dans le cadre d'une alimentation équilibrée
- Not recommended for (according to the manufacturer)
- Femmes enceintes
Declaration 156240, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Retiré du marché le 9 October 2024, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Trigonella foenum-graecum L. | Graine | Poudre (de plantes séchées ou broyées) | 990 mg |
Other ingredients
gélatine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ne pas dépasser la dose journalière recommandée
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : ACB PHARMA